Comparison between 2 local anaesthetic drugs in stellate ganglion block in patients scheduled for upper limb bone surgeries and their effect on requirement of post operative pain relieving drug.

Tramadol sparing effect of 0.5% ropivacaine versus 2% lignocaine in preoperative stellate ganglion block in upper limb orthopaedic surgeries.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012216

Enrollment

Registered

2018-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing upper limb orthopaedic surgery

Interventions

Intervention1: Group 1: Patients will receive preoperative ultrasound guided SGB with 3 ml of 0.5% ropivacaine.: Patients will receive preoperative ultrasound guided SGB with 3 ml of 0.5% ropivacaine.

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patiens scheduled for upper limb orthopaedic surgery. 2.ASA physical status 1 and 2 of either sex. 3.Age between 18 to 60 years. 4.BMI between 18 to 30 kilogram per metre square

Exclusion criteria

Exclusion criteria: 1.Patients refusal for the procedure. 2.Patients having haemodynamic instability. 3.Patients with coagulopathy and bleeding disorders. 4.Preexisting peripheral neuropathy. 5.Preexisting local infection at the site of block. 6.Patients having history of drug or substance abuse. 7.Inability to understand functioning of PCA pump and VAS. 8.Contraindication to study drugs lignocaine, ropivacaine and tramadol. 9.Patients on chronic pain management drugs. 10.Patients with simultaneous acute postoperative pain other parts of the body. 11.Contraindication to general anesthesia.

Design outcomes

Primary

Measure	Time frame
To study tramadol sparing effect of 0.5% ropivaicaine versus 2% lignocaine in preoperative stellate ganglion block in upper limb orthopaedic surgeries.Timepoint: To study cumulative tramadol consumption at 24 hours. Tramadol consumption will be monitored at 0,2,4,6,8,12,24 hours interval.	—

Secondary

Measure	Time frame
To study perioperative pain relief, effect on haemodynamics and adverse effects of preoperative SGB in patients scheduled for upper limb orthopaedic surgeries.Timepoint: Preoperatively (baseline), immediately after block 0,5,10,15 minutes and followed by 2,4,6,8,12 and 24 hours interval.	—

Countries

India

Contacts

Public ContactDr Deepak Thapa

Government medical college and hospital, sector-32, Chandigarh

ankitameena26@gmail.com9654008505

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026